IntelliGenes, a new software at Rutgers Health, uses artificial intelligence and machine learning to measure the significance of genomic biomarkers, potentially predicting diseases. The software, which merges traditional statistical methods with state-of-the-art algorithms, is intuitive enough for non-experts to use. In a study, IntelliGenes was used to discover novel biomarkers and accurately predict cardiovascular disease.
HSCC CWG urges halting NPRM, calls for joint cybersecurity policy reform to boost healthcare resilience
The Cybersecurity Working Group (CWG) within the U.S. Healthcare and Public Health Sector Coordinating Council (HSCC) has called on the country’s federal administration to work
